Bulletin
Investor Alert

New York Markets Open in:

Deciphera Pharmaceuticals Inc.

NAS: DCPH

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Oct 21, 2021, 4:54 p.m.

/zigman2/quotes/203556943/composite

$

34.04

Change

0.00 0.00%

Volume

Volume 6,699

Quotes are delayed by 20 min

/zigman2/quotes/203556943/composite

Previous close

$ 34.21

$ 34.04

Change

-0.17 -0.50%

Day low

Day high

$33.80

$35.00

Open

52 week low

52 week high

$26.20

$68.40

Open

Thomas P. Kelly

Currently, Thomas P. Kelly holds the position of Chief Financial Officer, Treasurer & Executive VP of Deciphera Pharmaceuticals, Inc.

In his past career he held the position of Associate of Foley Hoag LLP, CFO, SVP-Finance & Corporate Development at Critical Therapeutics, Inc., Chief Financial Officer at AdvanDx, Inc., Chief Financial Officer of Deciphera Pharmaceuticals LLC, Chief Financial Officer of deCODE genetics, Principal at Canaccord Adams, Inc. and Vice President-Life Sciences Investment Banking at Robertson Stephens, Inc.

Mr. Kelly received an undergraduate degree from Georgetown University, a graduate degree from The University of Chicago Law School and an undergraduate degree from Edmund A. Walsh School of Foreign Service.

Transactions

Date Shares Transaction Value
02/16/2021 11,100   Award at $0 per share. 0
02/16/2021 524   Disposition at $48.87 per share. 25,608
09/14/2020 3,000   Disposition at $50.01 per share. 150,030
09/14/2020 3,000   Derivative/Non-derivative trans. at $1.89 per share. 5,670
09/10/2020 3,000   Disposition at $47.71 per share. 143,130
09/10/2020 3,000   Derivative/Non-derivative trans. at $1.89 per share. 5,670
09/08/2020 1,500   Disposition at $46.55 per share. 69,825
09/08/2020 3,700   Disposition at $45.23 per share. 167,351
09/08/2020 800   Disposition at $44.69 per share. 35,752
09/08/2020 6,000   Derivative/Non-derivative trans. at $1.89 per share. 11,340
05/11/2020 2,605   Disposition at $55.56 per share. 144,734
05/11/2020 9,395   Disposition at $55.08 per share. 517,477
05/11/2020 12,000   Derivative/Non-derivative trans. at $1.89 per share. 22,680
02/18/2020 7,040   Award at $0 per share. 0
01/03/2020 966   Disposition at $58.14 per share. 56,164
01/03/2020 2,793   Disposition at $57.22 per share. 159,816
01/03/2020 500   Disposition at $56.26 per share. 28,130
01/03/2020 4,359   Derivative/Non-derivative trans. at $1.89 per share. 8,238
01/03/2020 100   Disposition at $58.74 per share. 5,874
01/02/2020 100   Disposition at $62.25 per share. 6,225
01/02/2020 200   Disposition at $59.48 per share. 11,896
01/02/2020 1,981   Disposition at $58.16 per share. 115,215
01/02/2020 5,360   Disposition at $57.54 per share. 308,415
01/02/2020 7,641   Derivative/Non-derivative trans. at $1.89 per share. 14,441
12/23/2019 40,000   Disposition at $68.21 per share. 2,728,400
12/23/2019 40,000   Derivative/Non-derivative trans. at $1.89 per share. 75,600
10/28/2019 3,750   Disposition at $40 per share. 150,000
10/28/2019 3,750   Derivative/Non-derivative trans. at $1.89 per share. 7,087
09/11/2019 3,090   Disposition at $35.43 per share. 109,479
09/11/2019 8,160   Disposition at $34.8 per share. 283,968
09/11/2019 11,250   Derivative/Non-derivative trans. at $1.89 per share. 21,262
08/13/2019 400   Disposition at $42.92 per share. 17,168
08/13/2019 3,586   Disposition at $42.25 per share. 151,509
08/13/2019 7,264   Disposition at $40.69 per share. 295,573
08/13/2019 11,250   Derivative/Non-derivative trans. at $1.89 per share. 21,262
06/19/2019 177   Disposition at $25 per share. 4,425
06/19/2019 177   Derivative/Non-derivative trans. at $1.89 per share. 334
06/03/2019 2,100   Disposition at $25.2 per share. 52,920
06/03/2019 2,100   Derivative/Non-derivative trans. at $1.89 per share. 3,969
05/22/2019 100   Disposition at $25 per share. 2,500
05/22/2019 100   Derivative/Non-derivative trans. at $1.89 per share. 189
05/21/2019 1,373   Disposition at $25.07 per share. 34,422
05/21/2019 1,373   Derivative/Non-derivative trans. at $1.89 per share. 2,594
05/01/2019 13,500   Disposition at $22.93 per share. 309,555
05/01/2019 13,500   Derivative/Non-derivative trans. at $1.89 per share. 25,515
02/19/2019 1,500   Disposition at $30 per share. 45,000
02/19/2019 1,500   Derivative/Non-derivative trans. at $1.89 per share. 2,835
01/07/2019 5,000   Disposition at $25.18 per share. 125,900
01/07/2019 5,000   Derivative/Non-derivative trans. at $1.89 per share. 9,450

Officers and Executives

Mr. Steven L. Hoerter
President, Chief Executive Officer & Director
Mr. Thomas P. Kelly
Chief Financial Officer, Treasurer & Executive VP
Dr. Matthew L. Sherman
Chief Medical Officer & Executive Vice President
Dr. Daniel L. Flynn
Chief Scientific Officer & Executive VP
Dr. Stephen B. Ruddy
Chief Technical Officer
Mr. Eric Haltom
Senior Vice President-Clinical Operations
Mr. Daniel C. Martin
Chief Commercial Officer
Ms. Jennifer Robinson
Head-Investor Relations
Ms. Caroline Chevalier
Vice President-Human Resources
Mr. Jeffrey M. Held
General Counsel & Senior Vice President
Mr. Jama Pitman
Vice President-Regulatory & Quality Assurance
Dr. James A. Bristol
Chairman
Dr. Susan L. Kelley
Independent Director
Mr. Ron Squarer
Independent Director
Mr. Franklin S. Friedman
Independent Director
Ms. Patricia L. Allen
Independent Director
Dr. Edward J. Benz
Independent Director
Mr. John R. Martin
Independent Director
Mr. Dennis L. Walsh
Independent Director
Trending Tickers
  • /zigman2/quotes/200467500/composite NVDA+6.20%
  • /zigman2/quotes/201948298/composite BABA-5.69%
  • /zigman2/quotes/202092269/composite ENSC+36.10%
  • /zigman2/quotes/200164174/composite SNOA+74.50%
  • /zigman2/quotes/207683784/composite TIGR-10.38%
X
Powered by StockTwits
Link to MarketWatch's Slice.